Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ADCC”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Study completedNCT03693300
What this trial is testing

Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 117
Early research (Phase 1)Study completedNCT03816137
What this trial is testing

Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens

Who this might be right for
HIV-1-infection
Imperial College London 117
Large-scale testing (Phase 3)Active Not RecruitingNCT03217422
What this trial is testing

ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

Who this might be right for
Autoimmune Hepatitis
Novartis Pharmaceuticals 68
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Early research (Phase 1)Ended earlyNCT03759184
What this trial is testing

Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia

Who this might be right for
LeukemiaLymphocyticChronic+1 more
National Cancer Institute (NCI) 1
Early research (Phase 1)Study completedNCT04185220
What this trial is testing

Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome

Who this might be right for
Adult T-Cell Lymphoma/LeukemiaSezary SyndromeMycosis Fungoides
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Early research (Phase 1)Ended earlyNCT05930951
What this trial is testing

Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Who this might be right for
Adenoid Cystic Carcinoma of the Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 19
Testing effectiveness (Phase 2)Looking for participantsNCT03874026
What this trial is testing

Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients

Who this might be right for
Colorectal CancerADCC
National Cancer Institute, Naples 34
Not applicableStudy completedNCT05093192
What this trial is testing

Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia

Who this might be right for
Chronic Lymphocytic LeukemiaMinimal Residual Disease
University of Bath 26
Early research (Phase 1)Study completedNCT02983006
What this trial is testing

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
NYU Langone Health 12
Early research (Phase 1)Ended earlyNCT05462873
What this trial is testing

Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellEsophageal Squamous Cell Carcinoma+1 more
Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)Ended earlyNCT05099549
What this trial is testing

Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers

Who this might be right for
Squamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell LungColorectal Neoplasms+3 more
NKGen Biotech, Inc. 11
Early research (Phase 1)WithdrawnNCT05700630
What this trial is testing

Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia

Who this might be right for
HIV-1-infectionARTCd4+ Lymphocyte Deficiency+2 more
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Ended earlyNCT04150562
What this trial is testing

Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma

Who this might be right for
Clear-Cell Renal Carcinoma
National Cancer Institute (NCI) 2
Early research (Phase 1)Study completedNCT03319459
What this trial is testing

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

Who this might be right for
HER2 Positive Gastric CancerColorectal CancerHead and Neck Squamous Cell Carcinoma+8 more
Fate Therapeutics 44
Early research (Phase 1)Study completedNCT01447732
What this trial is testing

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid TumourAdenocarcinoma of the ColorectalAdenocarcinoma of the Pancreas
Kyowa Kirin Co., Ltd. 71
Early research (Phase 1)Study completedNCT00525447
What this trial is testing

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Seagen Inc. 36
Early research (Phase 1)UnknownNCT03554889
What this trial is testing

Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells

Who this might be right for
Advanced CancerADCCNK Cell Mediated Immunity+2 more
Hangzhou Cancer Hospital 21
Early research (Phase 1)Study completedNCT03905135
What this trial is testing

Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies

Who this might be right for
Peripheral T-cell Lymphoma NOSMycosis FungoidesSezary Syndrome+1 more
National Cancer Institute (NCI) 8
Load More Results